Invivyd Inc (NAS:IVVD)

$ 1.385 0.095 (7.36%) Market Cap: 164.65 Mil Enterprise Value: -33.71 Mil PE Ratio: 0 PB Ratio: 0.92 GF Score: 22/100

Q3 2023 Invivyd Inc Earnings Call Transcript
Nov 09, 2023

$1.4 (-7.89%)

Earnings
Invivyd Inc at Guggenheim Securities Inflammation & Immunology Conference Transcript
Nov 07, 2023
Invivyd Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023
Q2 2023 Invivyd Inc Earnings Call Transcript
Aug 10, 2023

$1.55 (-0.64%)

Earnings
Invivyd Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2023
Q1 2023 Invivyd Inc Earnings Call Transcript
May 11, 2023

$1.43 (+0.70%)

Earnings
Invivyd Inc at H.C. Wainwright BioConnect Investor Conference Transcript
May 02, 2023
Full Year 2022 Invivyd Inc Earnings Call Transcript
Mar 23, 2023

$1.43 (+0.70%)

Earnings
Q3 2022 Invivyd Inc Earnings Call Transcript
Nov 10, 2022

$3.56 (+7.55%)

Earnings

Q3 2023 Invivyd Inc Earnings Call Transcript

Nov 09, 2023 / 09:30PM GMT

Release Date Price: $1.4 (-7.89%)

Transcript 8-K10-Q

Operator

Welcome to the Invivyd third-quarter 2023 financial results and recent business highlights call. (Operator Instructions) Please be advised that today's conference call is being recorded.

I would now like to hand the conference over to Scott Young, Senior Vice President of Investor Relations and in Corporate Communications. Please go ahead.

Scott Young

Invivyd, Inc. - SVP, IR & Corporate Communications

Thank you, operator. A short while ago, we issued a press release announcing our third-quarter 2023 financial results and business highlights. That press release and the slides we're using today on the webcast can be found in the Investors section of the Invivyd website under News and Events.

Today's discussion will be led by David Hering, Invivyd's Chief Executive Officer. He's joined by Dr. Pete Schmidt, Chief Medical Officer; Jeremy Gowler, Chief Operating and Commercial Officer; and Bill Duke, Chief Financial Officer.

During today's discussion, we will be making forward-looking statements concerning, among other things, the

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.